Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)

Authors: Ala'a Alkerwi, Nicolas Sauvageot, Anne-Françoise Donneau, Marie-Lise Lair, Sophie Couffignal, Jean Beissel, Charles Delagardelle, Yolande Wagener, Adelin Albert, Michèle Guillaume

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

The ORISCAV-LUX study is the first baseline survey of an on-going cardiovascular health monitoring programme in Grand-Duchy of Luxembourg. The main objectives of the present manuscript were 1) to describe the study design and conduct, and 2) to present the salient outcomes of the study, in particular the prevalence of the potentially modifiable and treatable cardiovascular disease risk factors in the adult population residing in Luxembourg.

Method

ORISCAV-LUX is a cross-sectional study based on a random sample of 4496 subjects, stratified by gender, age categories and district, drawn from the national insurance registry of 18-69 years aged Luxembourg residents, assuming a response rate of 30% and a proportion of 5% of institutionalized subjects in each stratum. The cardiovascular health status was assessed by means of a self-administered questionnaire, clinical and anthropometric measures, as well as by blood, urine and hair examinations. The potentially modifiable and treatable risk factors studied included smoking, hypertension, dyslipidemia, diabetes mellitus, and obesity. Both univariate and multivariate statistical analyses used weighted methods to account for the stratified sampling scheme.

Results

A total of 1432 subjects took part in the survey, yielding a participation rate of 32.2%. This figure is higher than the minimal sample size of 1285 subjects as estimated by power calculation. The most predominant cardiovascular risk factors were dyslipidemia (69.9%), hypertension (34.5%), smoking (22.3%), and obesity (20.9%), while diabetes amounted 4.4%. All prevalence rates increased with age (except smoking) with marked gender differences (except diabetes). There was a significant difference in the prevalence of hypertension and of lipid disorders by geographic region of birth. The proportion of subjects cumulating two or more cardiovascular risk factors increased remarkably with age and was more predominant in men than in women (P<0.0001). Only 14.7% of men and 23.1% of women were free of any cardiovascular risk factor. High prevalence of non-treated CVRF, notably for hypertension and dyslipidemia, were observed in the study population.

Conclusion

The population-based ORISCAV-LUX survey revealed a high prevalence of potentially modifiable and treatable cardiovascular risk factors among apparently healthy subjects; significant gender and age-specific differences were seen not only for single but also for combined risk factors. From a public health perspective, these preliminary findings stress the urgent need for early routine health examinations, preventive interventions and lifestyle behavioural changes, even in young asymptomatic adults, to decrease cardiovascular morbidity and mortality in Luxembourg.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brundtland GH: From the World Health Organization. Reducing risks to health, promoting healthy life. Jama. 2002, 288 (16): 1974-10.1001/jama.288.16.1974.CrossRefPubMed Brundtland GH: From the World Health Organization. Reducing risks to health, promoting healthy life. Jama. 2002, 288 (16): 1974-10.1001/jama.288.16.1974.CrossRefPubMed
2.
go back to reference Murray CJ, Lopez AD: Evidence-based health policy--lessons from the Global Burden of Disease Study. Science. 1996, 274 (5288): 740-743. 10.1126/science.274.5288.740.CrossRefPubMed Murray CJ, Lopez AD: Evidence-based health policy--lessons from the Global Burden of Disease Study. Science. 1996, 274 (5288): 740-743. 10.1126/science.274.5288.740.CrossRefPubMed
3.
go back to reference Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD: Clustering of cardiovascular disease risk factors. Prev Med. 1980, 9 (4): 525-533. 10.1016/0091-7435(80)90047-X.CrossRefPubMed Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD: Clustering of cardiovascular disease risk factors. Prev Med. 1980, 9 (4): 525-533. 10.1016/0091-7435(80)90047-X.CrossRefPubMed
4.
go back to reference Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS: Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol. 1987, 125 (3): 364-372.PubMed Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS: Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol. 1987, 125 (3): 364-372.PubMed
5.
go back to reference Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM: Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. The American journal of clinical nutrition. 1998, 67 (6): 1141-1146.PubMed Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM: Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. The American journal of clinical nutrition. 1998, 67 (6): 1141-1146.PubMed
6.
go back to reference Engstrom G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, Janzon L: Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke. 2001, 32 (5): 1098-1103.CrossRefPubMed Engstrom G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, Janzon L: Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke. 2001, 32 (5): 1098-1103.CrossRefPubMed
7.
go back to reference Keys A: Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet. 1980, 2 (8195 pt 1): 603-606. 10.1016/S0140-6736(80)90280-9.CrossRefPubMed Keys A: Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet. 1980, 2 (8195 pt 1): 603-606. 10.1016/S0140-6736(80)90280-9.CrossRefPubMed
8.
go back to reference Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M: Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972, 287 (16): 781-787. 10.1056/NEJM197210192871601.CrossRefPubMed Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M: Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972, 287 (16): 781-787. 10.1056/NEJM197210192871601.CrossRefPubMed
9.
go back to reference MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990, 335 (8692): 765-774. 10.1016/0140-6736(90)90878-9.CrossRefPubMed MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990, 335 (8692): 765-774. 10.1016/0140-6736(90)90878-9.CrossRefPubMed
10.
go back to reference Savage PJ: Treatment of diabetes mellitus to reduce its chronic cardiovascular complications. Curr Opin Cardiol. 1998, 13 (2): 131-138. 10.1097/00001573-199803000-00010.CrossRefPubMed Savage PJ: Treatment of diabetes mellitus to reduce its chronic cardiovascular complications. Curr Opin Cardiol. 1998, 13 (2): 131-138. 10.1097/00001573-199803000-00010.CrossRefPubMed
11.
go back to reference Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990, 322 (13): 882-889. 10.1056/NEJM199003293221303.CrossRefPubMed Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990, 322 (13): 882-889. 10.1056/NEJM199003293221303.CrossRefPubMed
12.
go back to reference Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R: Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol. 1987, 126 (4): 629-637.PubMed Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R: Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol. 1987, 126 (4): 629-637.PubMed
13.
go back to reference Hjermann I, Velve Byre K, Holme I, Leren P: Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet. 1981, 2 (8259): 1303-1310. 10.1016/S0140-6736(81)91338-6.CrossRefPubMed Hjermann I, Velve Byre K, Holme I, Leren P: Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet. 1981, 2 (8259): 1303-1310. 10.1016/S0140-6736(81)91338-6.CrossRefPubMed
14.
go back to reference Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990, 336 (8708): 129-133. 10.1016/0140-6736(90)91656-U.CrossRefPubMed Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990, 336 (8708): 129-133. 10.1016/0140-6736(90)91656-U.CrossRefPubMed
15.
go back to reference Vartiainen E, Sarti C, Tuomilehto J, Kuulasmaa K: Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?. Bmj. 1995, 310 (6984): 901-904.CrossRefPubMedPubMedCentral Vartiainen E, Sarti C, Tuomilehto J, Kuulasmaa K: Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?. Bmj. 1995, 310 (6984): 901-904.CrossRefPubMedPubMedCentral
16.
go back to reference Report WHO: Action plan for the global strategy for the prevention and control of non communicable diseases 2008-2013. WHO edition. 2008, 42- Report WHO: Action plan for the global strategy for the prevention and control of non communicable diseases 2008-2013. WHO edition. 2008, 42-
17.
go back to reference Rayner M PS: European cardiovascular disease statistics. 2000 Rayner M PS: European cardiovascular disease statistics. 2000
18.
go back to reference National Statistics of all causes of death, Statistiques des causes de décès, Direction de la Santé. Ministry of Health edition.: Directorate of Health, Ministry of Health, Luxembourg National Statistics of all causes of death, Statistiques des causes de décès, Direction de la Santé. Ministry of Health edition.: Directorate of Health, Ministry of Health, Luxembourg
19.
go back to reference Report of the inter-regional groupe of work on the Project Pôle de prévention cardiovasculaire transfrontalier-INTERREG IIIA, Mortalité, morbidité et facteurs de risque cardiovasculaire en Wallonie, Lorraine, Luxembourg - Recensement des données existantes, comparaisons et premières conclusions. 2005 Report of the inter-regional groupe of work on the Project Pôle de prévention cardiovasculaire transfrontalier-INTERREG IIIA, Mortalité, morbidité et facteurs de risque cardiovasculaire en Wallonie, Lorraine, Luxembourg - Recensement des données existantes, comparaisons et premières conclusions. 2005
20.
go back to reference Lwanga SK, Lemeshow S: Sample Size Determination in Health Studies: A Practical Manual. 1991 Lwanga SK, Lemeshow S: Sample Size Determination in Health Studies: A Practical Manual. 1991
21.
go back to reference Alkerwi A, Sauvageot N, Couffignal S, Albert A, Lair M-L, Guillaume M: Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. BMC Medical Research Methodology. Submitted article(MS ID: 1492936804367602) Alkerwi A, Sauvageot N, Couffignal S, Albert A, Lair M-L, Guillaume M: Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. BMC Medical Research Methodology. Submitted article(MS ID: 1492936804367602)
22.
go back to reference Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L, Bosch J, Sigouin C, Teo KK, Lonn E, et al: The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. Can J Cardiol. 1998, 14 (11): 1349-1357.PubMed Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L, Bosch J, Sigouin C, Teo KK, Lonn E, et al: The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. Can J Cardiol. 1998, 14 (11): 1349-1357.PubMed
23.
go back to reference El Assaad MA, Topouchian JA, Darne BM, Asmar RG: Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002, 7 (4): 237-241. 10.1097/00126097-200208000-00006.CrossRefPubMed El Assaad MA, Topouchian JA, Darne BM, Asmar RG: Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002, 7 (4): 237-241. 10.1097/00126097-200208000-00006.CrossRefPubMed
24.
go back to reference Report WHO: Obesity: preventing and managing the global epidemic. Geneva, Switzerland. Edited by: Organization WH. 1998 Report WHO: Obesity: preventing and managing the global epidemic. Geneva, Switzerland. Edited by: Organization WH. 1998
25.
go back to reference Clinical Guidelines on the Identification and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998, 6 (Suppl 2): 51S-209S. Clinical Guidelines on the Identification and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998, 6 (Suppl 2): 51S-209S.
26.
go back to reference Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007, 25 (6): 1105-1187. 10.1097/HJH.0b013e3281fc975a.CrossRefPubMed Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007, 25 (6): 1105-1187. 10.1097/HJH.0b013e3281fc975a.CrossRefPubMed
27.
go back to reference Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, et al: [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]. Rev Esp Cardiol. 2007, 60 (5): 1e-64e.PubMed Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, et al: [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]. Rev Esp Cardiol. 2007, 60 (5): 1e-64e.PubMed
28.
go back to reference Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, et al: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28 (1): 88-136. 10.1093/eurheartj/ehm124.PubMed Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, et al: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28 (1): 88-136. 10.1093/eurheartj/ehm124.PubMed
29.
go back to reference De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, et al: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003, 24 (17): 1601-1610. 10.1016/S0195-668X(03)00347-6.CrossRefPubMed De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, et al: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003, 24 (17): 1601-1610. 10.1016/S0195-668X(03)00347-6.CrossRefPubMed
30.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiology in review. 2005, 13 (6): 322-327.PubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiology in review. 2005, 13 (6): 322-327.PubMed
31.
go back to reference Rosengren A, Wilhelmsen L: Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Goteborg. Ann Epidemiol. 1997, 7 (1): 69-75. 10.1016/S1047-2797(96)00106-8.CrossRefPubMed Rosengren A, Wilhelmsen L: Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Goteborg. Ann Epidemiol. 1997, 7 (1): 69-75. 10.1016/S1047-2797(96)00106-8.CrossRefPubMed
32.
go back to reference Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, et al: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994, 89 (3): 975-990.CrossRefPubMed Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, et al: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994, 89 (3): 975-990.CrossRefPubMed
33.
go back to reference Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H: Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003, 19 (11): 1249-1259.PubMed Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H: Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003, 19 (11): 1249-1259.PubMed
34.
go back to reference Giampaoli S, Palmieri L, Dima F, Pilotto L, Vescio MF, Vanuzzo D: [Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory]. Ital Heart J Suppl. 2001, 2 (3): 294-302.PubMed Giampaoli S, Palmieri L, Dima F, Pilotto L, Vescio MF, Vanuzzo D: [Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory]. Ital Heart J Suppl. 2001, 2 (3): 294-302.PubMed
35.
go back to reference Gabriel R, Alonso M, Segura A, Tormo MJ, Artigao LM, Banegas JR, Brotons C, Elosua R, Fernandez-Cruz A, Muniz J, et al: Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. Rev Esp Cardiol. 2008, 61 (10): 1030-1040. 10.1157/13126043.CrossRefPubMed Gabriel R, Alonso M, Segura A, Tormo MJ, Artigao LM, Banegas JR, Brotons C, Elosua R, Fernandez-Cruz A, Muniz J, et al: Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. Rev Esp Cardiol. 2008, 61 (10): 1030-1040. 10.1157/13126043.CrossRefPubMed
36.
go back to reference Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, et al: The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008, 8: 6-10.1186/1471-2261-8-6.CrossRefPubMedPubMedCentral Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, et al: The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008, 8: 6-10.1186/1471-2261-8-6.CrossRefPubMedPubMedCentral
37.
go back to reference Welin L, Adlerberth A, Caidahl K, Eriksson H, Hansson PO, Johansson S, Rosengren A, Svardsudd K, Welin C, Wilhelmsen L: Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health. 2008, 8: 403-10.1186/1471-2458-8-403.CrossRefPubMedPubMedCentral Welin L, Adlerberth A, Caidahl K, Eriksson H, Hansson PO, Johansson S, Rosengren A, Svardsudd K, Welin C, Wilhelmsen L: Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health. 2008, 8: 403-10.1186/1471-2458-8-403.CrossRefPubMedPubMedCentral
38.
go back to reference Guindon GE, Boisclair , David : Past, Current and Future Trends in Tobacco Use. UC San Francisco: Center for Tobacco Control Research and Education. 2003 Guindon GE, Boisclair , David : Past, Current and Future Trends in Tobacco Use. UC San Francisco: Center for Tobacco Control Research and Education. 2003
39.
go back to reference Steptoe A, Wardle J, Smith H, Kopp M, Skrabski A, Vinck J, Zotti AM: Tobacco smoking in young adults from 21 European countries: association with attitudes and risk awareness. Addiction. 1995, 90 (4): 571-582. 10.1111/j.1360-0443.1995.tb02192.x.CrossRefPubMed Steptoe A, Wardle J, Smith H, Kopp M, Skrabski A, Vinck J, Zotti AM: Tobacco smoking in young adults from 21 European countries: association with attitudes and risk awareness. Addiction. 1995, 90 (4): 571-582. 10.1111/j.1360-0443.1995.tb02192.x.CrossRefPubMed
40.
go back to reference Ezzati M, Henley SJ, Thun MJ, Lopez AD: Role of smoking in global and regional cardiovascular mortality. Circulation. 2005, 112 (4): 489-497. 10.1161/CIRCULATIONAHA.104.521708.CrossRefPubMed Ezzati M, Henley SJ, Thun MJ, Lopez AD: Role of smoking in global and regional cardiovascular mortality. Circulation. 2005, 112 (4): 489-497. 10.1161/CIRCULATIONAHA.104.521708.CrossRefPubMed
41.
go back to reference Koya DL, Egede LE: Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med. 2007, 22 (6): 841-846. 10.1007/s11606-007-0163-y.CrossRefPubMedPubMedCentral Koya DL, Egede LE: Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med. 2007, 22 (6): 841-846. 10.1007/s11606-007-0163-y.CrossRefPubMedPubMedCentral
42.
go back to reference Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB: Clustering of metabolic factors and coronary heart disease. Archives of internal medicine. 1999, 159 (10): 1104-1109. 10.1001/archinte.159.10.1104.CrossRefPubMed Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB: Clustering of metabolic factors and coronary heart disease. Archives of internal medicine. 1999, 159 (10): 1104-1109. 10.1001/archinte.159.10.1104.CrossRefPubMed
43.
go back to reference Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G: Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism: clinical and experimental. 1996, 45 (6): 699-706.CrossRef Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G: Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism: clinical and experimental. 1996, 45 (6): 699-706.CrossRef
44.
go back to reference Bertsias G, Mammas I, Linardakis M, Kafatos A: Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC Public Health. 2003, 3: 3-10.1186/1471-2458-3-3.CrossRefPubMedPubMedCentral Bertsias G, Mammas I, Linardakis M, Kafatos A: Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC Public Health. 2003, 3: 3-10.1186/1471-2458-3-3.CrossRefPubMedPubMedCentral
45.
go back to reference Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006, 6: 9-10.1186/1471-2458-6-9.CrossRefPubMedPubMedCentral Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006, 6: 9-10.1186/1471-2458-6-9.CrossRefPubMedPubMedCentral
46.
go back to reference Strong K, Bonita R: Rapport SurF1. Surveillance des facteurs de risque liés aux maladies non transmissibles: état actuel des données mondiales. Organisation mondiale de la santé. 2003 Strong K, Bonita R: Rapport SurF1. Surveillance des facteurs de risque liés aux maladies non transmissibles: état actuel des données mondiales. Organisation mondiale de la santé. 2003
Metadata
Title
First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)
Authors
Ala'a Alkerwi
Nicolas Sauvageot
Anne-Françoise Donneau
Marie-Lise Lair
Sophie Couffignal
Jean Beissel
Charles Delagardelle
Yolande Wagener
Adelin Albert
Michèle Guillaume
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-468

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue